SEC Company Response from MiNK Therapeutics, (INKT) — Nov 7, 2022
MiNK Therapeutics, Inc.
Date: Nov. 7, 2022 · CIK: 0001840229 · Accession: 0001193125-22-278982
AI Filing Summary & Sentiment
File numbers found in text: 333-268143
Letter
MiNK Therapeutics, Inc.
149 Fifth Street, Suite 500
New York, NY 10010
November 7, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Re: MiNK Therapeutics, Inc.
Registration Statement on Form S-3 (File No. 333-268143)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on November 8, 2022, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please notify Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663 as soon as the registration statement has been declared effective.
[Signature page follows]
U.S Securities and Exchange Commission
Page 2
Very truly yours,
MiNK Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP MiNK Therapeutics, Inc. 149 Fifth Street, Suite 500 New York, NY 10010 November 7, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: MiNK Therapeutics, Inc. Registration Statement on Form S-3 (File No. 333-268143) Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on November 8, 2022, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Please notify Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663 as soon as the registration statement has been declared effective. [Signature page follows] U.S Securities and Exchange Commission Page 2 Very truly yours, MiNK Therapeutics, Inc. By: /s/ Jennifer S. Buell, Ph.D. Jennifer S. Buell, Ph.D. President, Chief Executive Officer and Director [Signature Page to Acceleration Request Letter]